Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates (CARSK)
Canadian-Australasian Randomised Trial of Screening Kidney Transplant Candidates for Coronary Artery Disease
Sponsor: University of British Columbia
This NA trial investigates Cardiovascular Diseases and Dialysis Related Complication and is currently actively recruiting participants. University of British Columbia leads this study, which shows 12 recorded versions since 2018 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
12 versions recorded-
Sep 2025 — Present [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Recruiting NA
-
Dec 2022 — Jun 2024 [monthly]
Recruiting NA
▶ Show 7 earlier versions
-
May 2021 — Dec 2022 [monthly]
Recruiting NA
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
Jun 2020 — Jan 2021 [monthly]
Recruiting NA
-
May 2020 — Jun 2020 [monthly]
Recruiting NA
-
Apr 2020 — May 2020 [monthly]
Recruiting NA
-
Mar 2019 — Apr 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2018 — Mar 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of British Columbia
- University of Sydney
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Berlin, Germany , Brighton, United Kingdom , Brixton, United Kingdom , Carshalton, United Kingdom , Edmonton, Canada , Halifax, Canada , Hamilton, Canada , Kingston, Canada , Laval, Canada , London, Canada and 8 more locations